Tetragon Financial Management LP 13D/13G Filings for Freeline Therapeutics Holdings plc (FRLN)

Tetragon Financial Management LP 13D and 13G filings for Freeline Therapeutics Holdings plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-01-31
4:15 pm
Purchase
2022-12-31 13G Freeline Therapeutics Holdings plc
FRLN
Tetragon Financial Management LP 266,667
6.200%
20,000increase
(+8.11%)
Filing
2022-03-21
11:10 am
Purchase
2022-03-10 13G Freeline Therapeutics Holdings plc
FRLN
Tetragon Financial Management LP 246,667
6.100%
246,667increase
(New Position)
Filing